CITIC Capital offers to buy China Biologic in deal valuing firm at $3.65b

By
Posted

The unit, CCRE, offered $110 in cash for each share of China Biologic it does not already own.

Primavera Capital

Malaysia’s Affin Hwang marks official launch of PE business with Bintang Capital

By

Bintang Capital will focus on mid-sized companies based in the Asia Pacific.


Myanmar’s Delta Capital hits final close of second fund at about $70m, falls short of $100m target

By

Combining with its Fund II, Delta Capital’s total assets under management has reached close to $120 million.


Singapore GIC, China’s CIC, Korea’s NPS among top 10 largest investors in PE in 2018

By

33 investors from Asia have allotted over $1B to PE in 2018.


India: Distressed asset funds eye buyout deals ahead of bankruptcy process

By

In a recent deal, India Resurgent Fund (IRF), a JV between Piramal Enterprises and Bain Capital Credit, invested Rs 800 crore in Archean Chemical Industries Ltd, buying out its lenders


India: SeaLink Capital buys OrbiMed stake in Surya Children’s Medicare, injects $30m

By

This is SeaLink’s second deal from debut fund after NephroPlus Health in August 2016.


India: TPG’s Growth’s The Rise Fund invests $70m in solar power co Fourth Partner Energy

By

In 2015, the Hyderabad-based solar energy company had raised $2 million from clean tech fund, Infuse Ventures and others.


PH pension fund GSIS to continue infra investments via Macquarie-managed vehicle

By

GSIS has committed to invest $314 million in Philippine Investment Alliance for Infrastructure (Pinai) fund,


Tencent leads 10% acquisition of PUBG-maker Bluehole for $500m: Report

By

The deal values the South Korean games maker Bluehole at over $5 billion.


Australia: Oaktree Capital-backed DDH1 acquires Strike Drilling

By

DDH1 continues to seek acquisition opportunities in the drilling space.